168 related articles for article (PubMed ID: 33988262)
1. The prevalence of potential drug-drug interactions in adults with intellectual disability.
McMahon M; Hatton C; Bowring DL; Hardy C; Preston NJ
J Intellect Disabil Res; 2021 Oct; 65(10):930-940. PubMed ID: 33988262
[TBL] [Abstract][Full Text] [Related]
2. Polypharmacy and psychotropic polypharmacy in adults with intellectual disability: a cross-sectional total population study.
McMahon M; Hatton C; Bowring DL
J Intellect Disabil Res; 2020 Nov; 64(11):834-851. PubMed ID: 32902029
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy.
Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C
Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and Factors Associated with Potential Drug-Drug Interactions in Older Community-Dwelling Adults: A Prospective Cohort Study.
Hughes JE; Russo V; Walsh C; Menditto E; Bennett K; Cahir C
Drugs Aging; 2021 Nov; 38(11):1025-1037. PubMed ID: 34632551
[TBL] [Abstract][Full Text] [Related]
5. Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States.
Sheikh-Taha M; Asmar M
BMC Geriatr; 2021 Apr; 21(1):233. PubMed ID: 33827442
[TBL] [Abstract][Full Text] [Related]
6. Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan: a retrospective computerized screening study.
Lin CF; Wang CY; Bai CH
Drugs Aging; 2011 Mar; 28(3):219-25. PubMed ID: 21250763
[TBL] [Abstract][Full Text] [Related]
7. Analysis of drug use in institutionalized individuals with intellectual disability and tube feeding.
Joos E; Mehuys E; Remon JP; Van Winckel M; Boussery K
Acta Clin Belg; 2016 Apr; 71(2):76-80. PubMed ID: 27075803
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of drug-drug interactions in older people before and after hospital admission: analysis from the OPERAM trial.
Zerah L; Henrard S; Wilting I; O'Mahony D; Rodondi N; Dalleur O; Dalton K; Knol W; Haschke M; Spinewine A
BMC Geriatr; 2021 Oct; 21(1):571. PubMed ID: 34663238
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, patterns and factors associated with psychotropic use in older adults with intellectual disabilities in Ireland.
O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
J Intellect Disabil Res; 2017 Oct; 61(10):969-983. PubMed ID: 28639298
[TBL] [Abstract][Full Text] [Related]
10. Prescribed Versus Taken Polypharmacy and Drug-Drug Interactions in Older Cardiovascular Patients during the COVID-19 Pandemic: Observational Cross-Sectional Analytical Study.
Anfinogenova ND; Novikova OM; Trubacheva IA; Efimova EV; Chesalov NP; Ussov WY; Maksimova AS; Shelkovnikova TA; Ryumshina NI; Stepanov VA; Popov SV; Repin AN
J Clin Med; 2023 Aug; 12(15):. PubMed ID: 37568464
[TBL] [Abstract][Full Text] [Related]
11. Use of comedications and potential drug-drug interactions in people living with HIV in China.
Chen R; Chen J; Tang Q; Meng Z; Luo L; Zhang W; Deng A; Zhang L; Wang J; Qi T; Zhang R; Shen Y; Liu L; Steinhart C; Lu H
J Infect Chemother; 2020 Jul; 26(7):722-728. PubMed ID: 32354599
[TBL] [Abstract][Full Text] [Related]
12. Polypharmacy, drug-drug interactions, and adverse drug reactions among systemic sclerosis patients: A cross-sectional risk factor study.
Boukhlal S; Chouchana L; Saadi M; Casadevall M; Cohen P; Dunogue B; Murarasu A; Regent A; Mouthon L; Chaigne B
Semin Arthritis Rheum; 2024 Aug; 67():152469. PubMed ID: 38781783
[TBL] [Abstract][Full Text] [Related]
13. Characterization of drug-drug interactions in patients whose substance intake was objectively identified by detection in urine.
Schrecker J; Puet B; Hild C; Schwope DM
Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):973-978. PubMed ID: 30092669
[TBL] [Abstract][Full Text] [Related]
14. Exposure to potentially inappropriate drugs and drug-drug interactions in elderly nursing home residents in Helsinki, Finland: a cross-sectional study.
Hosia-Randell HM; Muurinen SM; Pitkälä KH
Drugs Aging; 2008; 25(8):683-92. PubMed ID: 18665660
[TBL] [Abstract][Full Text] [Related]
15. Medication burden and frailty in older adults with intellectual disability: An observational cross-sectional study.
O'Connell J; Henman MC; McMahon N; Burke É; McCallion P; McCarron M; O'Dwyer M
Pharmacoepidemiol Drug Saf; 2020 Apr; 29(4):482-492. PubMed ID: 32134549
[TBL] [Abstract][Full Text] [Related]
16. Psychotropic medication use for adults and older adults with intellectual disability; selective review, recommendations and future directions.
Deutsch SI; Burket JA
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110017. PubMed ID: 32544599
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and associated factors of polypharmacy in older patients in primary care: a northern Italian cross-sectional study.
Piccoliori G; Mahlknecht A; Sandri M; Valentini M; Vögele A; Schmid S; Deflorian F; Engl A; Sönnichsen A; Wiedermann C
BMC Geriatr; 2021 Mar; 21(1):197. PubMed ID: 33743582
[TBL] [Abstract][Full Text] [Related]
18. Clinically relevant drug-drug interactions among elderly people with dementia.
Sönnerstam E; Sjölander M; Lövheim H; Gustafsson M
Eur J Clin Pharmacol; 2018 Oct; 74(10):1351-1360. PubMed ID: 29967921
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and factors associated with polypharmacy in Victorian adults with intellectual disability.
Haider SI; Ansari Z; Vaughan L; Matters H; Emerson E
Res Dev Disabil; 2014 Nov; 35(11):3071-80. PubMed ID: 25129201
[TBL] [Abstract][Full Text] [Related]
20. Clinically important potential drug-drug interactions in outpatient settings.
Aparasu R; Baer R; Aparasu A
Res Social Adm Pharm; 2007 Dec; 3(4):426-37. PubMed ID: 18082877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
